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Abstract
Study objective To evaluate the implementation of the
Ohio Emergency and Acute Care Facility Opioids and Other
Controlled Substances Prescribing Guidelines and their
perceived impact on local policies and practice.
Methods The study design was a cross-sectional survey
of emergency department (ED) medical directors, or
appropriate person identified by the hospital, perception
of the impact of the Ohio ED Opioid Prescribing Guidelines
on their departments practice. All hospitals with an ED in
Ohio were contacted throughout October and November
2016. Distribution followed Dillman’s Tailored Design
Method, augmented with telephone recruitment. Hospital
chief executive officers were contacted when necessary
to encourage ED participation. Descriptive statistics were
used to assess the impact of opioid prescribing policies on
prescribing practices.
Results A 92% response rate was obtained (150/163
EDs). In total, 112 (75%) of the respondents stated that
their ED has an opioid prescribing policy, is adopting one or
is implementing prescribing guidelines without a specific
policy. Of these 112 EDs, 81 (72%) based their policy on
the Ohio ED Opioid Prescribing Guidelines. The majority of
respondents strongly agreed/agreed that the prescribing
guidelines have increased the use of the prescription
drug monitoring programme (86%) and have reduced
inappropriate opioid prescribing (71%).
Conclusion This study showed that the Ohio ED Opioid
Prescribing Guidelines have been widely disseminated and
that the majority of EDs in Ohio are using them to develop
local policies. The majority of respondents believed
that the Ohio opioid prescribing guidelines reduced
inappropriate opioid prescribing. However, prescribing
practices still varied greatly between EDs.

Introduction
Background
Drug overdoses are the leading cause of unintentional death in the USA, driven largely by
opioids (66%), both prescription and illicit.1 2
In total, 40% of opioid-related deaths are due

Strengths and limitations of this study
►► All emergency departments (EDs) in hospitals in

Ohio were included in the study.
►► A large response rate of 92% (150/163) was ob-

tained for the survey.
►► Survey reported ED medical directors’ perceptions

of prescribing practices in their EDs.
►► Survey results are self-reported and may be influ-

enced by recall or social desirability bias.

to a prescription opioid, with the remainder
primarily driven by heroin and illicitly manufactured fentanyl (IMF).3 Although heroin
and IMF-related deaths are the primary cause
of opioid-related deaths in the USA, there
are significant geographical variations in
opioid prescribing practices and involvement
of specific opioid compounds in overdose
deaths.2 4 Reducing unnecessary exposure to
prescription opioids may prevent the development of opioid use disorder that is later
supplemented or replaced by illicit opioids.5
This has led to the implementation of
multiple strategies aimed at improving opioid
prescribing around the USA.2 6 Such strategies appear to be improving the situations in
some states, as the rates of overdose deaths
involving a prescription (age adjusted) have
steadied from 2011 to 20155 and the annual
opioid prescribing rate has decreased from
2012 to 2015.4
This paper will focus on strategies used in
the emergency room setting in Ohio, as Ohio
had the third highest rate of prescription
opioid-related overdose deaths and highest
number of prescription opioid-related
overdose deaths in the USA in 2016.7 Ohio
has persistently had high overdose deaths
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Table 1 Characteristics of respondents and their hospitals
(n=150)
Respondents’ position

n (%)

Medical director
Emergency physician

119 (79.3)
19 (12.7)

Nursing director

9 (6.0)

Pharmacist

3 (2.0)

Rural
 Urban

86 (57.3)

 Rural

64 (42.7)

Region of Ohio
 Central

21 (14.0)

 Northeast

48 (32.0)

 Northwest

34 (22.7)

 Southeast

15 (10.0)

 Southwest

32 (21.3)

Hospital funding type
 Non-government not for profit

130 (86.7)

 Government non-federal

16 (10.7)

 Investor owned for profit

4 (2.7)

Hospital classification
 Short-term acute hospital
 Critical access hospital
 Children’s hospital

115 (76.7)
32 (21.3)
3 (2.0)

over the last decade and has been comprehensive in its
approach to reduce them.5 8 Many state-based initiatives
were developed by the Governor’s Cabinet Opiate Action
Team (GCOAT) and have also included the development
of numerous opioid prescribing guidelines. This includes
the Ohio Emergency and Acute Care Facility Opioids and
Other Controlled Substances Prescribing Guidelines,
referred to as the Ohio emergency department (ED)
Opioid Prescribing Guidelines, in 2012.9 Similar guidelines have been released by the American College of
Emergency Physicians (ACEP) in 2012.10 The Ohio guidelines were endorsed and publicised by nine organisations,
including the Ohio chapter of the ACEP, the Ohio State
Medical Association and the Ohio Hospital Association.9
Physicians working in ED may require assistance as it has
been estimated that up to 42% of EDs may be misused by
patients.11 Development and dissemination of high-quality
clinical practice guidelines can assist physicians in making
informed prescribing decisions while mitigating the risks
associated with medications, such as opioids. A qualitative
study of 61 emergency physicians presented at the 2012
national ACEP research and education conference found
that, in general, physicians viewed opioid prescribing guidelines in EDs favourably.12 They believed the guidelines
assisted in standardising practice patterns at the institutional level, reduced the frequency and dosage of opioid
prescriptions, improved patient safety and protected them
2

from liability and patient complaints. However, it was also
noted that many physicians were unaware of specific recommendations listed in the guidelines.12 Recent evidence
further supports this as opioid prescribing has declined in
Ohio by ED physicians since the release of the Ohio ED
Opioid Prescribing Guidelines.13 However, it is unknown
which recommendations in the guidelines have led to this
change and which ones may need to be refined. The Ohio
Department of Health (ODH) contracted with our research
team to evaluate the extent to which the Ohio ED Opioid
Prescribing Guidelines have been implemented in hospitals
with an ED in Ohio.9 As a result, this study aimed to evaluate
the implementation of the Ohio ED Opioid Prescribing
Guidelines and their perceived impact on hospital policies
and practices.

Methods
Study design, setting and survey development
The study design was a cross-sectional survey of ED medical
directors, or appropriate person identified by the hospital,
in all Ohio hospitals with an ED throughout October
and November 2016. A 10-question survey based on the
Ohio ED Opioid Prescribing Guidelines was developed
by experts on the research team who have experience in
survey design and opioid prescribing in EDs. A literature
review and input from ODH also ensured content validity
of the survey. The survey instrument included primarily
closed-ended questions using a Likert-scale to evaluate
the implementation of the guidelines and local opioid
policies. Questions were chosen to correspond with each
recommendation in the guideline. Additional questions
focused on the respondents’ demographic details, strategies used to implement the guidelines and the perceived
benefits of the guidelines. Once developed, the survey
was pretested for key elements of accessibility, usability
and understandability by five ED medical directors and
physicians. The final survey was then made available as a
paper version and a web-based version using (Research
Electronic Data Capture (REDCap)).14
Selection of participants
The survey was designed to be completed by one person
at each hospital ED in Ohio. The survey targeted ED
medical directors or those identified by ED personnel
as the most appropriate person to complete the survey.
Hospitals with an ED in Ohio were identified through the
ODH Office of Health Assurance and Licensing. As of
September 2016, 271 hospitals were registered in Ohio;
164 of these hospitals had an ED; however, 1 hospital had
closed just prior to the study commencement. Hospitals’
mailing addresses, phone numbers and an email address
for their respective chief executive officer (CEO) were
obtained from hospital registration reports.
Survey distribution followed Dillman’s Tailored Design
Method, a mixed-mode method including postal mail and
email, augmented by telephone interviews to maximise
the response rate.15 Dillman’s Tailored Design Method is
Penm J, et al. BMJ Open 2018;8:e020477. doi:10.1136/bmjopen-2017-020477
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Figure 1 Perceived impact of the Ohio ED Opioid Prescribing Guidelines from respondents who follow an opioid prescribing
policy (n = 106).

based on social exchange theory, which focuses on establishing trust, increasing benefits and decreasing costs, to
improve response rates.15 One strategy recommend by
Dillman is to provide participants with a token of appreciation in advance. This token can be as small as US$2 as
it increases the benefit and establishes trust.15 A US$10
incentive was chosen as it was the smallest amount that
could be preloaded on a prepaid credit card.
All hospitals in Ohio with an ED were initially telephoned (day 0) to inform potential participants about
the survey and to offer to complete the survey over the
phone. If potential participants were unavailable or
unable to complete the survey over the phone, a letter
was mailed with a web-link to the survey and a US$10
incentive (day 1). A letter containing a US$10 incentive
was also mailed to the hospital’s CEO asking the CEO to
pass the survey web-link to the potential participant (day
1). Three days later (day 4), the letters were followed up
with an email to both the potential participant and the
hospital’s CEO. If no response was received, a reminder
email was sent on day 10, a hard copy of the survey was
mailed on day 18 and a final reminder email was sent on
day 22. To further increase the response rate, a reminder
was sent to rural hospitals through the ODH State Office
of Rural Health and to ED physicians through the Ohio
Chapter of the ACEP. These emails were sent on day 4
with a reminder sent a week later. The most senior ED
physicians’ responses were used for hospitals where the
ED medical director could not be contacted or identified.
Patient and public involvement
This study was designed and conducted by the research
team with assistance from the Ohio ODH. Patients and
the public were not involved in this study.
Penm J, et al. BMJ Open 2018;8:e020477. doi:10.1136/bmjopen-2017-020477

Analysis
All survey data were managed using REDCap.14 Hospitals
were classified as being urban or rural based on the Federal
Office of Rural Health Policy definition. Descriptive statistics, reported as percentages, were used to summarise the
demographics and survey responses. All analyses were
performed using Stata SE V.13.1 (StataCorp).

Results
Characteristics of study subjects
ED personnel at 163 hospitals were contacted to participate in this study and 150 responses were received; yielding
92% response rate. Among those that responded, 57%
(86/150) were from urban hospitals and 43% (64/150)
were from rural hospitals. Table 1 shows the characteristics of respondents and their hospitals. The ED medical
director completed the survey for 79% (119/150) of the
EDs. For the remaining EDs, either an emergency physician (13%, 19/150), an ED nursing director (6%, 9/150)
or a pharmacist (2%, 3/150) completed the survey.
Main results
Implementation of Ohio opioid prescribing policy
Overall, 75% (112/150) of respondents stated that their
ED either had an opioid prescribing policy, was in the
process of adopting one or was implementing guidelines without a specific policy. Of these 112 EDs, 72%
(81/112) based their policy and practices on the Ohio
ED Opioid Prescribing Guidelines. Other prescribing
guidelines on which respondents based their policies
and practices were the ACEP guidelines (34%, 38/112),
the Centers for Disease Control and Prevention (CDC)
guidelines (29%, 32/112) and the American Academy
3
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Figure 2

Strategies used to implement opioid prescribing policies and guidelines (n = 106).

of Emergency Medicine (AAEM) guidelines (13%,
15/112).
Among the EDs that reported developing or having
an opioid prescribing policy, the majority strongly
agreed/agreed that the guidelines have increased the
use of Ohio’s prescription drug monitoring programme
(86%) and the Ohio ED Opioid Prescribing Guidelines
have reduced inappropriate opioid prescribing (71%).

The other potential benefits of the Ohio ED Opioid
Prescribing Guidelines are displayed in figure 1.
The most common strategies used to implement opioid
prescribing policies and guidelines were developing
educational materials, adapting the educational materials locally to their patient population and using local
opinion leaders to encourage opioid prescribing policy
and guideline implementation (figure 2).

Table 2 Respondents’ perception of frequency of opioid treatment in the last month in their emergency department (n=134)*
Never

1%–4%

5%–24%

25%–49%

≥50%

Provided to patients with acute pain

n (%)

Intravenous meperidine
Opioid prescription that:

114 (85)

13 (10)

5 (4)

0 (0)

0 (0)

 Is long acting or controlled release

110 (82)

18 (13)

2 (1)

0 (0)

0 (0)

91 (68)
30 (22)

31 (23)
49 (37)

4 (3)
30 (22)

0 (0)
15 (11)

0 (0)
3 (2)

Intramuscular or intravenous opioids
Intravenous meperidine

6 (4)
118 (88)

34 (25)
11 (8)

52 (39)
0 (0)

24 (18)
0 (0)

9 (7)
0 (0)

Replacement doses of opioid substitution therapy

121 (90)

5 (4)

1 (1)

0 (0)

0 (0)

113 (84)

16 (12)

1 (1)

1 (1)

0 (0)

 Replaces those lost, destroyed or stolen

97 (72)

26 (19)

3 (2)

0 (0)

0 (0)

 Is for more than a 3-day supply

52 (39)

43 (32)

23 (17)

10 (7)

0 (0)

27 (20)

49 (37)

36 (27)

9 (7)

2 (1)

20 (15)

64 (48)

30 (22)

9 (7)

0 (0)

 Replaces those lost, destroyed or stolen
 Is for more than a 3-day supply
Provided to patients with chronic pain

Opioid prescription that:
 Is long acting or controlled release

Opioid prescription for:
 Patients who received an opioid prescription within
past month
 Patients who presented with the same problem within
past month

*Although there were 134 respondents, some responded as ‘do not know’ or did not complete this specific question and are not represented
in the table.
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Opioid prescribing practices
Table 2 shows respondents’ perceptions of opioid
prescribing practices for pain in the last month in their
EDs. For the management of acute pain, respondents
rarely (<5% of patients) used intravenous meperidine,
provided a prescription for long-acting or controlled-release opioids, or replaced opioids that were lost, destroyed
or stolen as recommended in the guidelines. However,
one-third of respondents (33%) reported writing an
opioid prescription for more than 3 days for 5% or more
of their patients with acute pain. For the management of
chronic pain, respondents rarely (<5% of patients) used
intravenous meperidine, provided a prescription for longacting or controlled-release opioids, replaced opioids that
were lost, destroyed or stolen, or provided replacement

doses of opioid replacement therapy as recommended in
the guidelines. However, 64% of respondents reported
using intramuscular or intravenous opioids in 5% or
more of their patients with chronic pain. Also, approximately one-third of respondents provided a prescription
for opioids in 5% or more of their patients with chronic
pain who: (1) had received an opioid prescription from
another provider and (2) had previously presented with
the same problem in the last month.
Opioid prescribing procedure
Table 3 shows respondents’ perceptions of tasks
performed, recommended in the guidelines, for any
opioid prescription written in the last month in their EDs.
Large variations were reported from EDs around Ohio.

Table 3 Respondents’ perception of tasks performed when giving an opioid prescription in the last month in their ED (n=134)*
Never
Task performed
Confirmed identity by
photo identification
Searched the Ohio
prescription monitoring
programme

1%–4%

5%–24%

25%–49%

50%–74%

75%–95%

>95%

n (%)
23 (17)

4 (3)

9 (7)

2 (1)

5 (4)

23 (17)

31 (23)

1 (1)

8 (6)

17 (13)

25 (19)

27 (20)

33 (25)

16 (12)

Completed urine or
other drug screen

16 (12)

50 (37)

37 (28)

7 (5)

3 (2)

4 (3)

1 (1)

Obtained records from
other providers

16 (12)

39 (29)

24 (18)

17 (13)

8 (6)

8 (6)

7 (5)

For patients with
chronic pain,
contacted their routine
opioid prescriber

7 (5)

54 (40)

34 (25)

16 (12)

9 (7)

1 (1)

1 (1)

For patients who visit
the ED frequently,
conducted a case
review or management

30 (22)

30 (22)

21 (16)

13 (10)

5 (4)

18 (13)

2 (1)

Obtained a
consultation from the
hospital’s palliative or
pain service

59 (44)

50 (37)

10 (7)

2 (1)

0 (0)

0 (0)

1 (1)

108 (81)

14 (10)

3 (2)

1 (1)

0 (0)

1 (1)

1 (1)

Had patients sign a
pain agreement

Provide patients with written information on:
 Addictive nature of
opioids

31 (23)

16 (12)

5 (4)

10 (7)

4 (3)

13 (10)

31 (23)

 Potential dangers of
the opioid misuse

31 (23)

21 (16)

5 (4)

10 (7)

3 (2)

13 (10)

31 (23)

43 (32)

14 (10)

8 (6)

8 (6)

3 (2)

4 (3)

24 (18)

44 (33)

14 (10)

18 (13)

13 (10)

5 (4)

6 (4)

7 (5)

 Appropriate storage
and disposal of
opioids
 The facility’s
policy regarding
the prescribing of
opioids

*Some rows do not add up to 100% (n=134) as ‘do not know’ or incomplete responses are not included in the table.
ED, emergency department.
Penm J, et al. BMJ Open 2018;8:e020477. doi:10.1136/bmjopen-2017-020477
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For example, 23% of EDs provided written information
on the addictive nature of opioids to more than 95% of
their patients who received an opioid prescription, while
another 23% of EDs never did. Some recommendations
in the guidelines were also largely not implemented.
Over 80% of EDs never get patients who are prescribed
an opioid to sign a pain agreement, and 44% reported
that they never receive a consultation from the hospital’s
palliative or pain service.
Discussion
This study found that the majority of Ohio EDs are aware
of the need to improve appropriate opioid prescribing
and either have a hospital-based opioid prescribing policy,
are in the process of adopting one or are implementing
guidelines without a specific policy. Most EDs are aware
of the Ohio ED Opioid Prescribing Guidelines and are
using them to be more judicious in opioid prescribing
decisions. The results of this study demonstrate that ED
medical directors, and their delegates, in Ohio believe
that the Ohio ED Opioid Prescribing Guidelines have
at least been partially implemented and have formed
the basis for hospital-level prescribing policies. Factors
suggesting that the Ohio ED Opioid Prescribing Guidelines were influential include the number of respondents
who reported familiarity, perceived impact in terms of
improved opioid prescribing and an increase in the use
of the Ohio prescription drug monitoring programme.
These findings are consistent with recent evidence that
indicated a decline in opioid prescribing by Ohio ED
physicians since the release of the Ohio ED Opioid
Prescribing Guidelines.13 This successful implementation
of the guidelines may, in part, be due to the multistakeholder input that led to the development of the guidelines and broad support from professional societies and
government officials. The fact that they are being implemented so widely indicates that the guidelines offer
reasonable advice to ED physicians.
Although respondents generally reported their ED
practices aligned with the Ohio ED Opioid Prescribing
Guidelines, variability in ED prescribing practices was
also observed. The largest variability in ED prescribing
practices was the percentage of patient with chronic pain
treated with intramuscular or intravenous opioids. Also,
large variability was observed in the percentage of patients
being given a prescription for an opioid for more than 3
days, regardless if it was for chronic or acute pain. Such
prescribing variability may highlight that these specific
guideline recommendations may not be practical or that
respondents generally do not agree with them. A revision of these statements and guidance on which clinical
scenario they apply to may ensure the guidelines support
best practices.
Furthermore, similar variability in ED practices was
observed, including the use of Ohio’s prescription
drug monitoring programme and education provided
to patients. The largest variation in ED practices was
6

observed for opioid prescriptions being provided to
patients with chronic pain even though they had previously presented with the same problem or had received
an opioid prescription from another provider in the last
month. This lack of standardisation in the care and information patients receive is concerning and requires additional investigation to identify their cause.
It is also acknowledged that ED physicians make a relatively small contribution to the overall number of opioids
prescribed. In Ohio, ED physicians write approximately
5% of all opioid prescriptions.16
Hence, guidelines aimed at primary care practitioners
that commonly prescribe opioids should also be implemented, such as those developed by the GCOAT17 18 or
the CDC.19 However, Barnett et al20 showed that longterm opioid use is associated with initial exposure from
high-intensity ED prescribers. As ED prescribers do not
regularly prescribe opioids long term, it is hypothesised
that conversion to long-term use may be driven by clinical
‘inertia,’ whereby outpatient clinicians renew previous
prescriptions. Our findings suggest that ED physicians may
initiate clinical ‘inertia’ due to the fact that approximately
30% of respondents acknowledged that they prescribed
opioids to at least 5% of patients who presented with the
same problem in the last month. Despite the low number
of opioid prescriptions written in EDs, it is important to
acknowledge that the EDs are a source of repeat as well as
first-time opioid exposures.
Identifying patients who are using EDs for repeat
prescriptions is particularly challenging. There is
currently no mechanism in Ohio for ED physicians
to track patients who move from one ED to another.
Although the increased use of Ohio’s prescription
drug monitoring programme could assist with this, it
is not mandatory for ED physicians in Ohio to review
their records if they prescribe for fewer than 7 days.21
Our results highlight the variability of the programmes
utilisation, with only 12% of respondents stating they
used it for more than 95% of their patients prescribed
an opioid in the last month. Without mandatory use
of prescription drug monitoring programmes in EDs,
which may be administratively cumbersome, tracking
patients who move between EDs is beyond the current
healthcare systems capabilities.
These findings should be considered in light of
multiple limitations. In particular, we note that the survey
included self-reported data, which could be influenced
by recall or social desirability bias. The survey reported
ED medical directors’ perceptions of prescribing practices in their ED, which may not accurately reflect individual-level ED prescribing patterns. These data are also
not generalisable outside of Ohio and did not include
EDs not affiliated with hospitals. Furthermore, information related to the morphine milligram equivalent
per prescription was not obtained, which may provide
additional insight into the influence of the guidelines. Also, the introduction of the Ohio ED Opioid
Prescribing Guidelines occurred in parallel with other
Penm J, et al. BMJ Open 2018;8:e020477. doi:10.1136/bmjopen-2017-020477
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national-based and state-based interventions,5 10 so it is
not known if the Ohio ED Opioid Prescribing Guidelines changed prescribers’ views on opioid prescribing
or equipped already motivated prescribers with a tool
to defend their decision to limit opioid prescriptions.
The latter would be consistent with a prior report
which indicated that ED physicians used guidelines as a
communication tool to protect themselves from liability
and patient complaints rather than using them to influence their decision-making process.12
In conclusion, this study showed that the Ohio ED
Opioid Prescribing Guidelines have been widely disseminated, with the majority of EDs in Ohio using them to
develop hospital-based opioid prescribing policies. The
majority of respondents believed that opioid prescribing
guidelines have increased the use of the Ohio prescription
monitoring programme and have reduced inappropriate
opioid prescribing. Although the implementation of the
Ohio ED Opioid Prescribing Guidelines is promising,
further efforts to promote responsible opioid prescribing
in other specialties are also required.
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